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SIRT1 Promotes the Central Adaptive Response to Diet
Restriction through Activation of the Dorsomedial and
Lateral Nuclei of the Hypothalamus
Akiko Satoh,1 Cynthia S. Brace,1 Gal Ben-Josef,5 TimWest,2David F. Wozniak,3,4David M. Holtzman,1,2,4
Erik D. Herzog,4,5 and Shin-ichiro Imai1
Departments of 1Developmental Biology, 2Neurology, and 3Psychiatry and 4Hope Center for Neurological Disorders, Washington University School of
Medicine, St. Louis, Missouri 63110, and 5Department of Biology, Washington University, St. Louis, Missouri 63130
Diet restriction retards aging and extends lifespan by triggering adaptivemechanisms that alter behavioral, physiological, and biochem-
ical responses in mammals. Little is known about the molecular pathways evoking the corresponding central response. One factor that
mediates the effects of diet restriction is the mammalian nicotinamide adenine dinucleotide (NAD)-dependent deacetylase SIRT1. Here
we demonstrate that diet restriction significantly increases SIRT1 protein levels and induces neural activation in the dorsomedial and
lateral hypothalamic nuclei. Increasing SIRT1 in the brain of transgenic (BRASTO) mice enhances neural activity specifically in these
hypothalamic nuclei, maintains a higher range of body temperature, and promotes physical activity in response to different diet-
restricting paradigms. These responses are all abrogated in Sirt1-deficient mice. SIRT1 upregulates expression of the orexin type 2
receptor specifically in these hypothalamic nuclei in response to diet-restricting conditions, augmenting response to ghrelin, a gut
hormonewhose levels increase in these conditions.Our results suggest that in thehypothalamus, SIRT1 functions as akeymediator of the
central response to low nutritional availability, providing insight into the role of the hypothalamus in the regulation of metabolism and
aging in mammals.
Introduction
Animals employ a variety of strategies to survive when food is
limited, including adaptive mechanisms that alter their behav-
ioral, physiological, and biochemical responses to low nutritional
inputs. For example, it has been reported that animals reduce
their physical activity during the initial stages of food depriva-
tion, but increase it during the later stages (Wang et al., 2006).
This increase in physical activity could be an adaptive response to
search for food and to survive through such life-threatening con-
ditions. In rodents, the increase in physical activity has also been
observed in diet restriction (DR) (Yu et al., 1985; Ingram et al.,
1987), the single, most reliable regimen known to retard aging
and extend lifespan in a variety of organisms, including yeast (Lin
et al., 2000), worms (Lakowski and Hekimi, 1998), flies (Chapman
and Partridge, 1996), rodents (McCay et al., 1935; Weindruch and
Walford, 1982), and primates (Colman et al., 2009). DR has also
been known to delay the onset and slow the progression of many
age-relateddiseases (Weindruch et al., 1986; Bronson and Lipman,
1991; Fontana et al., 2004; Colman et al., 2009). Whereas a num-
ber of hypotheses have been proposed to explainmechanisms for
the physiological effects of DR (Masoro, 2005), recent evidence
suggests that DR triggers highly coordinated adaptive responses
that translate nutritional cues to alterations in fundamental cel-
lular processes, thereby mediating a variety of physiological re-
sponses at a systemic level (Sinclair, 2005; Bishop and Guarente,
2007a).
Although little is known about themechanisms of these adap-
tive responses to DR, the evolutionarily conserved Sir2 (silent
information regulator 2) family of NAD-dependent deacetylases/
ADP-ribosyltransferases, also called “sirtuins,” has recently
drawn much attention as a critical regulator that mediates phys-
iological responses to DR (Sinclair, 2005; Bishop and Guarente,
2007a; Imai, 2009a). Sirtuins play a critical role in the regulation
of aging and longevity in experimental model organisms, such as
yeast, worms, and flies (Kaeberlein et al., 1999; Tissenbaum and
Guarente, 2001; Rogina and Helfand, 2004). Sirtuins are also
required for the DR-mediated lifespan extension in those organ-
ismswith certain genetic backgrounds (Lin et al., 2000; Anderson
et al., 2003; Rogina and Helfand, 2004; Wang and Tissenbaum,
2006). In mammals, there are seven sirtuins, SIRT1 through
SIRT7. Numerous studies have demonstrated that SIRT1 regu-
lates essential metabolic pathways in response to low energy in-
take inmultiple tissues, as well as cell survival in response to stress
and damage (Sinclair, 2005; Imai and Guarente, 2007; Schwer
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and Verdin, 2008). Results from loss- and gain-of-function
mouse studies have provided genetic evidence connecting SIRT1
to DR (Imai, 2009a). For example, it has been reported that the
DR-induced elevation of physical activity is abrogated in Sirt1-
deficient mice (Chen et al., 2005), providing a clue for the poten-
tial role of SIRT1 in the central regulation of physiological
response to DR. Therefore, we decided to examine whether and
how SIRT1 controls central adaptive responses to DR using both
gain- and loss-of-function SIRT1 mutant mice. Our present
study reveals a novel function for SIRT1 in the hypothalamus,
particularly in the dorsomedial and lateral hypothalamic nuclei,
as a key mediator of the central adaptive response to DR. These
findings also provide important insight into the physiological
mechanism that conveys the anti-aging and the lifespan-
extending effects of DR in mammals.
Materials andMethods
BRASTO and Sirt1-deficient mice. To generate brain-specific SIRT1-
overexpressing (BRASTO) transgenic mice, the mouse prion (PrP)
promoter-driven, HA-tagged Sirt1 transgene was constructed by insert-
ing a 2.3 kb fragment of the mouse Sirt1 cDNA into the vector carrying
the mouse PrP promoter (Wang et al., 2005) (a kind gift from Dr. David
Borchelt, University of Florida, Gainesville, FL) after eliminating three
NotI sites without changing the SIRT1 amino acid sequence and adding
the HA tag to the 3 end of the Sirt1 coding sequence. The PrP-Sirt1-HA
transgene was linearized, purified, and microinjected into C57BL/6J 
CBA hybrid blastocysts in the Washington University Mouse Genetic
Core Facility. Transgenic mice were identified by PCR genotyping with
tail DNA. Two transgenic founders (lines 1 and 10) were established, and
the mice were backcrossed to wild-type C57BL/6 mice (Jackson Labora-
tories) for 6–7 generations before analysis. Nontransgenic littermates
were used as controls. Sirt1-deficient (Sirt1/) mice, which were orig-
inally established in the 129sv/B6 mixed background, were described
previously (Cheng et al., 2003). Sirt1-heterozygous mice were back-
crossed to wild-type FVBmice (Jackson Laboratories) for six generations
(a kind gift fromDr. JeffreyMilbrandt,WashingtonUniversity, St. Louis,
MO), and Sirt1/mice were generated by crossing Sirt1-heterozygous
mice. Sirt1/ FVB mice at 3–5 months of age were used for this study.
Diet-restricting paradigms. For 48 h fasting, chow was removed from
both male and female mice at 4–5 months of age at 8:30 A.M. for 48 h.
After 48 h fasting, the ambulatory behavior of mice was carefully re-
corded by a video camera, and physical activity was scored by counting
the number of times that each mouse crossed from one quadrant to
another over 10 min (supplemental Movies S1–4, available at www.
jneurosci.org as supplemental material). For DR, wild-type C57BL/6,
BRASTO, Sirt1/, and respective control male mice at 8–12 weeks of
agewere fedwith 1 g pellets of a semisynthetic chow, AIN-93M (Bioserv).
Ad libitum-fed (AL) control mice were given pellets equal to calculated
average daily food intake (4 pellets), while diet-restricted mice were
given pellets equal to 60% of average daily food intake. For short-term
DR (14 d), mice were fed everyday at 5:00 P.M. and killed between 9:00
A.M. and 10:00 A.M. To assess the effects of this short-term DR on
locomotor activity, the groups were tested over a 24 h (12 h/12 h light/
dark) period according to previously published procedures (Wozniak et
al., 2004). For long-term DR (104 d), the feeding cycle was as follows: 8
and 4–5 pellets on Monday and Wednesday and 10–11 and 6–7 pellets
on Friday for AL and DR mice, respectively, and chow was delivered
between 4:00 and 5:00 P.M. This DR regimenwith intermittent feeding is
to create conditions that allow us to conduct other physiological tests,
such as intraperitoneal glucose tolerance tests, as similar as possible to
regular procedures. In one of these DR experiments, for example, after 3
months of DR, glucose levels on Thursday morning were 150 6.9 and
105 4.5 mg/dl for AL and DR males, respectively, while glucose levels
on Friday morning were 130 6.0 and 76.4 6.1 mg/dl for AL and DR
males, respectively. Therefore, physiological tests that normally require
fasting before the experiments were usually conducted onWednesday or
Friday morning, and we confirmed that DR mice showed significantly
improved glucose tolerance (data not shown). However, to separate the
long-term effects of DR from those of fasting, tissue and plasma samples
were collected between 9:00 A.M. and 10:00 A.M. onTuesday andThurs-
day morning. For timed DR, male mice at 4–5 months of age were
maintained in 12 h/12 h light/dark schedule and housed individually
with a running wheel. Mice were fed only from 1:00 P.M. [zeitgeber time
6 (ZT6)] to 5:00 P.M. (ZT10). Running-wheel revolutions in 1 min bins
were recorded using Clocklab software (Actimetrics) as described previ-
ously (Aton et al., 2004). All animal procedures were approved by the
Washington University Animal Studies Committee.
Twenty-four-hour locomotor activity test. Starting at 10:00–10:30 A.M.,
locomotor activity was evaluated over a 24 h period by placing individual
mice into transparent (47.6  25.4  20.6 cm high) polystyrene enclo-
sures as described in previous studies involving a 1 h test (Wozniak et al.,
2004). Each enclosure was surrounded by a frame containing a 4  8
matrix of photocell pairs, the output of which was fed to an on-line
computer (Hamilton-Kinder). Another frame that contained eight pairs
of photocells and was raised 7 cm above the floor of the enclosure was
used to quantify vertical activity. Variables that were analyzed included
the total number of ambulations (whole-bodymovements), as well as the
number of vertical rearings over the 24 h period.
Rectal body temperature. Rectal body temperature was measured at
9:00–9:30 A.M. by aMicrotherma 2 Type (TW2-193) thermometer with
a mouse rectal probe (model RET-3).
Immunohistochemistry. Mice were anesthetized with ketamine/xyla-
zine and perfused with PBS followed by 4% paraformaldehyde (PFA).
Brains were fixed with 4% PFA overnight and placed into 15% sucrose
followed by 30% sucrose. Thirty-micrometer sections were made by a
cryostat and stored at30°C. Immunostaining results were analyzed for
each hypothalamic nucleus as follows: Because brain sections from one
mouse were used for multiple analyses, hypothalamic sections at the
same coronal planes were always chosen for all mice analyzed. For each
mouse, two brain sections around bregma0.82 mm were used for the
PVN and SCN and one to two brain sections around bregma1.58 mm
were used to cover the Arc, VMH, DMH, and LH.We usually used three
to four mice for each analysis and therefore analyzed four to eight sec-
tions per hypothalamic nucleus. When signals/counts were relatively
low, we analyzed more sections. To quantify SIRT1 protein signals in
each hypothalamic nucleus, brain sections were stained by 3,3-
diaminobenzidine (DAB) with rabbit anti-mouse SIRT1 (1:3000)
(Moynihan et al., 2005) and biotinylated goat anti-rabbit IgG (1:500)
antibodies with the ABC kit (Vector Laboratories). SIRT1 protein signals
were quantified bymeasuring the intensity per area in each hypothalamic
nucleus after subtracting surrounding background signal levels using the
Histogram function of Adobe Photoshop. For double immunofluores-
cent staining of HA-tagged SIRT1, samples were stained first with the
same rabbit anti-mouse SIRT1 (1:1000) and HRP-conjugated goat anti-
rabbit IgG (1:2000) antibodies using the FITC TSA kit (Parkin Elmer)
and then with anti-HA (1:1000, Covance) and HRP-conjugated goat
anti-mouse IgG (1:10,000) antibodies using the Cy3 TSA kit, according
to the manufacturer’s protocol. To stain cFOS in each hypothalamic
nucleus, samples were stained by the DAB detection method with anti-
cFOS (1:100,000, Calbiochem) and biotinylated goat anti-rabbit IgG (1:
200) antibodies with the ABC kit. The numbers of cFOS-positive cells
were quantified by ImageJ software. For the double staining of cFOS and
OX2R, samples were stained for cFOS first and then with anti-OX2R
(1:100, Alpha Diagnostics) and HRP-conjugated goat anti-rabbit IgG
(1:1000) antibodies with the Cy3 TSA kit.
In situ hybridization. Brain sections were fixed in 4% PFA, acetylated
with triethanol amine/acetic anhydrite, and prehybridized in hybridiza-
tion buffer (10 mM Tris-HCl [pH 7.4], 600 mM NaCl, 1 mM EDTA, 1
Denhardt’s solution, 25g/ml yeast ribosomal RNA, 12.5g/ml salmon
testis DNA, 10% dextran sulfate, and 40% formamide). Prehybridized
samples were then hybridized in hybridization buffer containing digoxi-
genin (DIG)-labeled antisense RNA probes of Ox2r (nucleotides 595-
1034) at 60°C overnight. Sense probes were used as negative controls.
After samples were hybridized, samples were sequentially washed with
2 SSC/50% formamide, 0.1 SSC, and washing buffer (100mMmaleic
acid, 150 mM NaCl, 0.3% Tween 20, pH 7.5) and then incubated with
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blocking solution (PerkinElmer). Signals were visualized by incubating
with a peroxidase-conjugated anti-DIG antibody and the TSA kit. The
signal intensity per area in each hypothalamic nucleus was quantified
after subtracting surrounding background signal levels by using the His-
togram function of Adobe Photoshop.
Laser-microdissection. The brain was removed, immediately frozen in
OCT compound on dry ice, and stored at 80°C until laser-microdis-
section. Twenty-five-micrometer brain sections were mounted on PEN-
membrane slides (Leica), and kept on dry ice. The mounted slides were
hydrated sequentially in 100%, 95%, 75%, and 50% ethanol for 30 s each.
The hydrated slides were stained with 1% Cresyl Violet (Sigma) for 1
min, and dehydrated with 50%, 75%, 95%, and 2 cycles of 100% ethanol
for 30 s each. The dehydrated slides were then incubated in xylene twice
for 1min each. After being air-dried for 5min, Arc, VMH,DMH, and LH
were microdissected using the Leica LMD 6000 laser-microdissection
system.
Quantitative real-time RT-PCR. Total RNA was extracted from each
hypothalamic nucleus using the RNeasy kit (Qiagen) and reverse-
transcribed into cDNAwith theHighCapacity cDNAReverse Transcrip-
tion kit (Applied Biosystems). Quantitative real-time RT-PCR was
conducted with the TaqMan Fast Universal PCRMaster mix and appro-
priate TaqManprimers for each gene in theGeneAmp7500 fast sequence
detection system (Applied Biosystems). Relative expression levels were
calculated for each gene by normalizing to Gapdh levels and then to one
of the wild-type control individuals.
Luciferase assay. HEK293 cells were transfected with a luciferase re-
porter driven by a1 kbOx2rpromoter and a Sirt1minigene or a control
vector (Revollo et al., 2004). Transfected cells were cultured in media
with 5 mM glucose for 48 h. Cell extracts were prepared, and luciferase
activity was determined with the Dual-Luciferase Reporter Assay System
(Promega) according to the manufacturer’s protocol. Luciferase activity
levels were normalized to protein concentrations of each sample.
Chromatin-immunoprecipitation assay. Mouse hypothalamus was in-
cubated sequentially with freshly prepared 5 mM DTBP and 1% PFA.
After washing with PBS, pellets were stored at 80°C until analysis.
Pellets were resuspended in buffer (1% Triton X-100, 0.1% deoxy-
cholate, 50 mM Tris-HCl [pH 8.1], 5 mM EDTA, 150 mM NaCl, 1% SDS,
and protease inhibitors) and placed on ice for 20 min. After centrifuga-
tion, chromatin was sheared by sonicating with nuclei buffer (50 mM
Tris-HCl, pH 8.0, 10mMEDTA, 0.01%SDS, and 0.1mMPMSF) to a final
size between 200 bp and 600 bp. Before immunoprecipitation, soluble
chromatin was incubated with protein A agarose/salmon slurry (Milli-
pore) at 4°C for 30 min. An aliquot of supernatant was removed as
“input” and used in PCR analysis. The remainder of supernatant was
incubated with SIRT1 antibody or rabbit IgG at 4°C overnight. Immune
complexes were isolated by incubating with protein A agarose/salmon
slurry for 1.5 h at 4°C. The complexes were washed with low-salt buffer,
high-salt buffer, LiCl buffer, and TE, pH 8.0. The complexes were eluted,
de-cross-linked with 125 mM NaCl at 65°C overnight, and then treated
with RNase A at 37°C for 30 min and with proteinase K at 45°C for 90
min. The purified DNA was resuspended with TE and analyzed by PCR
by specific primer sets.
Measurement of serum ghrelin levels.Mouse plasma samples were col-
lected into tubes containing 4-(2-aminoethyl)-benzenesulfonyl fluoride
(AEBSF, Sigma), incubated for 30 min at room temperature, and centri-
fuged at 5000 g for 10min at 4°C. The supernatantwas stored at30°C
until analysis. The levels of ghrelin in serum were determined by a rat/
mouse total ghrelin ELISA kit (LINCO Research).
Ghrelin administration.After 4 d of habituation to handling andmock
injection, BRASTO, Sirt1/, and control male mice were injected with
octanoylated rat ghrelin (Pi Proteomics) at a dose of 30 nmol/kg body
weight or with an equal volume of PBS. Ninety and one hundred twenty
minutes after injection, mice were anesthetized and killed to collect
brains.
Statistical analyses. Statistical analyses were performed using unpaired
or paired Student’s t tests for two groups and one-way ANOVA with the
Tukey–Kramer post hoc test for more than two groups. Two-way
ANOVA was also applied to the data shown in Figures 2A, 3D, 3E, 4A,
4D, 4E, 7A, and 7C, to assess themain effects of two different factors and
the interaction between them. For this analysis, full statistics are pre-
sented in supplemental Table S1 (available at www.jneurosci.org as sup-
plemental material). A Wilcoxon matched-pairs signed-ranks test was
used to compare differences of hourly wheel counts through the light and
dark times between wild-type versus BRASTOmice and day 0 vs day 5 in
each genotype, respectively. In all analyses, we set the  level at 0.05. We
used Microsoft Excel 2008 and SPSS 11.0 to conduct statistical analyses.
Results
SIRT1 is expressed in major hypothalamic nuclei
We initially surveyed the expression pattern of the SIRT1 protein
in the mouse brain using a rabbit polyclonal, affinity-purified
antibody (Imai et al., 2000). This antibody did not produce any
significant positive signals on Sirt1-deficient brain sections, as-
suring its specificity (supplemental Fig. S1A,B, available at www.
jneurosci.org as supplemental material). SIRT1 showed nuclear
localization in the hypothalamus and hippocampus, and ex-
tranuclear localization in dorsal regions of the cerebral cortex
(data not shown). In the hypothalamus, SIRT1 was expressed in
the arcuate nucleus (Arc), the ventromedial, dorsomedial, and
lateral hypothalamic nuclei (VMH, DMH, and LH, respectively),
and the paraventricular nucleus (PVN), brain regions that all play
critical roles in the central regulation of adaptive responses to
food availability (Elmquist, 2001) (Fig. 1A). SIRT1 was also ex-
pressed in the suprachiasmatic nucleus (SCN), a region impor-
tant for the central regulation of circadian rhythm (Green et al.,
2008) (Fig. 1A). These results are consistent with the reported
distribution of Sirt1 mRNA in the hypothalamus (Ramadori et
al., 2008).
Both SIRT1 levels and the number of activated neurons
increase in the DMH and LH of diet-restricted hypothalami
Because SIRT1 protein levels are upregulated and downregulated
in multiple tissues and even within the same tissue in response to
DR (Imai and Guarente, 2007; Chen et al., 2008; Schwer and
Verdin, 2008), we decided to examine whether SIRT1 protein
levels were also altered in hypothalamic nuclei of diet-restricted
mice. Using a semiquantitative DAB-based immunostaining
method with our highly specific SIRT1 antibody (supplemental
Fig. S1A,B, available at www.jneurosci.org as supplemental ma-
terial), we found that SIRT1 protein levels moderately but specif-
ically increased in the DMH, LH, and SCN, but not in the Arc,
VMH, or PVN, in response to short-term (14 d) DR (DMH, p
0.047; LH, p 0.043; SCN, p 0.007) (Fig. 1B; supplemental Fig.
S2, available at www.jneurosci.org as supplementalmaterial).We
also observed significant increases in the number of cFOS-
positive cells, a well established marker of neural activation
(Sagar et al., 1988; Dragunow and Faull, 1989), in the DMH and
LH under DR (DMH, p  0.019; LH, p  0.001) (Fig. 1C,D).
Neither the hippocampus nor the cortex showed any significant
increase in cFOS-positive cells (data not shown). Similar results
were obtained in hypothalami under long-term (104 d) DR (sup-
plemental Fig. S3A–D, available at www.jneurosci.org as supple-
mental material). These findings suggest that a moderate but
continuous increase in SIRT1 dosage and/or activity might play
an important role in neural activation in the DMH and LH in
response to DR.
To address this possibility, we generated transgenic mice in
which SIRT1 protein levels are selectively increased in the brain
(BRASTO). BRASTO transgenic mice express a C-terminally
HA-tagged mouse SIRT1 cDNA driven by the mouse prion pro-
moter (Fig. 1E). We established two independent BRASTO
transgenic lines, lines 1 and 10. Both lines showed moderate in-
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creases in SIRT1 protein expression in the brain (2.5- to 5.1- and
1.5- to 2.5-fold increases in lines 1 and 10, respectively) (Fig. 1E).
There were 2-fold increases in SIRT1 levels in the kidney in
both lines and heart in line 1 (supplemental Fig. S4A, available at
www.jneurosci.org as supplemental material). Interestingly, ex-
pression profiles of the overexpressed SIRT1 protein mimicked
that of endogenous SIRT1 (Fig. 1F; supplemental Fig. S4B, avail-
able atwww.jneurosci.org as supplementalmaterial). Particularly
in line 10, SIRT1 was overexpressed 2.7-fold in the DMH and
1.8-fold in the LH (supplemental Fig. S1B, right panel, available
at www.jneurosci.org as supplemental material), a similar profile
of increases in SIRT1 levels detected in the hypothalami of diet-
Figure 1. SIRT1 is expressed in major hypothalamic nuclei, and both SIRT1 levels and the number of activated neurons increase in the DMH and LH in diet-restricted hypothalami. A, Immuno-
fluorescent staining of SIRT1 (green) in major hypothalamic nuclei, including the PVN, SCN, Arc, VMH, DMH, and LH. Nuclei are counterstained by DAPI (gray). B, Signal intensities of SIRT1 staining
in hypothalami after 14 d DR compared to AL (*p 0.05, **p 0.01, n 4mice, 4– 8 sections per hypothalamic nucleus). The signal intensity per area was digitally quantified after subtracting
surrounding background. Results are shown asmean values SEM. C,D, cFOS staining in the DMH and LH after 14 d DR (C), and quantification of the number of cFOS-positive cells in hypothalamic
nuclei (*p 0.05, ***p 0.001, n 4 mice, 4– 8 sections per hypothalamic nucleus). The numbers of cFOS-positive cells are shown as mean values SEM (D). E, Transgene structure for the
production of BRASTOmice (upper panel) and distribution of SIRT1 inmajor brain regions in both lines 1 and 10 of BRASTOmice (lower panels). F, Immunofluorescent staining of SIRT1 (green) and
HA (red) in hypothalami of BRASTO line 10. Nuclei are counterstained by DAPI (gray).
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restricted wild-type mice (Fig. 1B). These
BRASTO mice were born normally and
did not show any gross abnormalities. We
examined their fed and fasted plasma glu-
cose and insulin levels, body weight, food
intake, and glucose and insulin tolerance
at the age of 5 months but did not detect
any significant differences between
BRASTO and control mice (supplemental
Fig. S5, available at www.jneurosci.org as
supplemental material).
BRASTOmice exhibit enhanced
physical activity in response to diverse
diet-restricting paradigms
During the course of ourmetabolic assess-
ments, we noticed that BRASTO female
mice were more active compared to con-
trol mice after 48 h fasting (supplemental
Movies S1–4, available at www.jneurosci.
org as supplemental material). When
quantitated, BRASTO females in both
lines 1 and 10 showed enhanced physical
activity compared to control mice after
48 h fasting (WT vs Tg, line 1, p 0.008;
line 10, p  0.076; percentage count, L1,
p 0.002; L10, p 0.060) (Fig. 2A; sup-
plemental Table S1, available at www.
jneurosci.org as supplemental material).
This phenotype was not obvious in
BRASTOmales, although there appears to
be a similar trend, particularly in line 10
(supplemental Fig. S6A, available at www.
jneurosci.org as supplemental material).
Therefore, instead of an acute fasting con-
dition, we evaluated the general locomo-
tor activity in BRASTO and control males
following a more chronic (14 d) DR con-
dition. Interestingly, while diet-restricted
BRASTO males showed a trend toward
more total ambulations (whole-body
movements) over a 24 h light/dark cycle, they exhibited signifi-
cantly higher counts of rearing (vertical activity) compared to
controls (light plus dark periods, p  0.049; dark period alone,
p  0.007) (Fig. 2B). This increase in rearing activity was more
obvious particularly during the dark period. Increases in rearing
often signify heightened arousal levels and augmented environ-
mental exploration and nonselective attention (Vallone et al.,
2002). Therefore, these findings suggest that bothBRASTOmales
and females have a greater propensity to increase their physical
activity compared to control mice in response to diet-restricting
conditions.
We also examined BRASTO and control mice in a different
experimental paradigm in which they were fed daily from 1:00
P.M. (ZT6) to 5:00 P.M. (ZT10). In this timed DR paradigm, the
food-anticipating activity (FAA) of mice significantly increases
within several days of timed DR (Mistlberger, 1994; Stephan,
2002). Under this paradigm, BRASTOmice in both lines 1 and 10
exhibited enhanced FAA compared to control mice after 5 d of
timedDR, although line 1 showed amuch larger variability (sup-
plemental Fig. S6B, available at www.jneurosci.org as supple-
mental material). Interestingly, BRASTO mice showed a greater
increase in their FAA during ZT0–6 ( p 0.03) (Fig. 2C), par-
ticularly ZT5–6 right before feeding time, and a greater decrease
in their night-time activity at ZT12–18 ( p  0.047) (Fig. 2C),
supporting the idea that BRASTO mice might be able to reallo-
cate their physical activity more efficiently than control mice,
with the plausible purpose of seeking food. Together, these find-
ings suggest that SIRT1 in the brain plays an important role in
promoting physical activity in response to different diet-
restricting conditions.
BRASTOmice show enhanced neural activation in the DMH
and LH in response to diet-restricting conditions
We next examined which brain regions were more highly acti-
vated in BRASTO mice than in controls in response to different
diet-restricting paradigms. In ad libitum conditions, there were
only very small numbers of cFOS-positive cells in both wild-type
and BRASTO hypothalami, except for the SCN that normally
shows circadian rhythms of neural activation (Gooley et al.,
2006), and no significant differences were observed between
wild-type and BRASTOmice (supplemental Fig. S7A, available at
www.jneurosci.org as supplemental material). After 48 h fasting,
90%, 46%, and 163% increases in the numbers of cFOS-positive
cells were detected in the DMH, LH, and PVN of BRASTOmice,
Figure2. BRASTOmiceexhibit enhancedphysical activity in response tomultiplediet-restrictingparadigms.A, Physical activity
levels of BRASTO female mice after 48 h fasting in line 1 (left) and line 10 (middle). Activity counts (the numbers of quadrants
crossed; left andmiddle) andpercentage counts relative to the fed condition (right) are shownasmeanvaluesSEM(**p0.01,
***p 0.001 by one-way ANOVAwith Tukey–Kramer post hoc test, n 9–12mice).B, Numbers of total ambulations (left) and
rearings (right) of BRASTO (Tg) and control (WT)malemice in line 10 after 14 d DR are shown asmean values SEM (*p 0.05,
**p 0.01, n 6mice). L/D, Light plus dark periods; D, dark period alone. C, Wheel-running activity levels of BRASTOmalemice
in line 10 during a timed DR paradigm. Activity counts per hour through a 24 h light/dark cycle are shown. Shading represents
feeding time (ZT6 to 10). Counts at each time point are shown as mean values SEM (day 0 vs day 5, *p 0.05, **p 0.01,
***p 0.001 by paired Student’s t or Wilcoxon matched-pairs signed-ranks tests; WT vs Tg, §p 0.05 by aWilcoxon matched-
pairs signed-ranks test; n 5–10 mice).
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respectively, compared to those of control mice (DMH, p 
0.0014; LH, p  0.048; PVN, p  0.002) (Fig. 3A; supplemental
Fig. S7B, available at www.jneurosci.org as supplemental mate-
rial). The profile of the increases in cFOS-positive cells in hypo-
thalamic nuclei of fasted BRASTOmicewere very similar to those
in diet-restricted wild-type mice (Fig. 1D), with the exception of
the additional neural activation in the PVN. As the PVN is known
to control the stress response through the stimulation of glu-
cocorticoid secretion from adrenal glands, this additional PVN
activation might correspond to a stress component imposed by
sustained food anticipation under 48 h fasting. Indeed, a small
but significant increase in plasma corticosterone levels was de-
tected in fasted BRASTO females, compared to those in control
fasted females (supplemental Fig. S8, available atwww.jneurosci.org
as supplementalmaterial). After 14 dDR, the BRASTODMHand
LH exhibited 32% and 43% increases in the numbers of cFOS-
positive cells, respectively, compared to those in control mice
(DMH, p 0.008; LH, p 0.049) (Fig. 3B; supplemental Fig. S7C,
available at www.jneurosci.org as supplemental material), whereas
other hypothalamic nuclei did not show
any significant differences between
BRASTO and control mice, further sup-
porting the importance of the DMH and
LH in response to diet-restricting condi-
tions. Because chow was always delivered
between 4:00 P.M. and 5:00 P.M. in this
DR regimen (seeMaterials andMethods),
the observed activation of the DMH and
LH does not appear to be related to the
time of feeding. In the timed DR para-
digm, 67% and 120% increases in the
numbers of cFOS-positive cells were de-
tected on day 5, first in theDMHand then
in the LH of BRASTO mice, respectively,
compared to those in control mice during
the 2 h time course before feeding (DMH,
p  0.034; LH, p  0.002) (Fig. 3C; sup-
plemental Fig. S7D, available at www.
jneurosci.org as supplemental material).
The SCN is known to show circadian
rhythms of neural activation peaking
around ZT6 (Gooley et al., 2006). SIRT1
appears to suppress this oscillatory pattern,
qualitatively consistent with the effect of
SIRT1 on peripheral circadian rhythms
(Nakahata et al., 2008; Ramsey et al., 2009).
Thus, themost important point concerning
these results is that the enhanced neural ac-
tivation in the DMH and LH is tightly asso-
ciated with increased physical activity in
BRASTO mice under all three diet-
restricting paradigms that we examined,
namely, 48 h fasting, DR, and timed DR.
To further confirm that the observed
enhancement of DMH and LH activation
in BRASTO hypothalami is physiologi-
cally relevant, we examined rectal body
temperature in BRASTO and control
mice in response to 48 h fasting andDR. It
has been demonstrated that neural acti-
vation in the DMH and LH plays an
important role in the induction of ther-
mogenesis in rodents (Cerri andMorrison,
2005; DiMicco and Zaretsky, 2007; Morrison et al., 2008). While
both BRASTO and control mice showed significant decreases in
rectal body temperature after 48 h fasting and 14 d DR, BRASTO
mice were able to maintain higher levels of rectal body tempera-
ture compared to controls (WT vs Tg, fasted, p 0.032; DR, p
0.023) (Fig. 3D,E; supplemental Table S1, available at www.
jneurosci.org as supplemental material), consistent with en-
hanced physical activity (Fig. 2A,B) and enhanced neural
activation in the DMH and LH (Fig. 3A,B) in fasted and diet-
restricted BRASTO mice. These results further support the im-
portance of SIRT1 in the regulation of neural activation in the
DMHand LH in response to different diet-restricting paradigms.
Sirt1-deficient mice exhibit defects in neurobehavioral
adaptation to diet-restricting conditions
To examine whether SIRT1 is necessary for neurobehavioral ad-
aptation to diet-restricting conditions, we decided to examine
Sirt1-deficient (Sirt1/) mice. Our Sirt1/ mice were back-
crossed to FVB. With this genetic background, Sirt1/ mice
Figure3. BRASTOmice showenhancedneural activation in theDMHand LH in response tomultiple diet-restricting paradigms.
A–C, Quantification of cFOS-positive cells in major hypothalamic nuclei after 48 h fasting (A), 14 d DR (B), and 5 d of timed DR (C)
in BRASTOmice in line 10 (*p 0.05, **p 0.01, n 4 for 48 h fasting and DR, 4–8 sections per hypothalamic nucleus; n 2
at each time point for timed DR, 2–5 sections per hypothalamic nucleus). The numbers of cFOS-positive cells are shown as mean
values SEM. D, E, Rectal body temperature of BRASTO mice after 48 h fasting (D) and during 14 d DR (E). Levels of rectal body
temperature are shown as mean values SEM (*p 0.05, **p 0.01, ***p 0.001 by one-way ANOVAwith Tukey–Kramer
post hoc test, n 6–7 for 48 h fasting, n 6 for DR).
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grow to adulthood with no significant
early mortality (A.S., C.S.B., and S.I., un-
published observation), despite their pre-
viously reported small body size (Cheng et
al., 2003; McBurney et al., 2003). We put
these Sirt1/mice under a 14 d DR and
examined the effects of this dietary change
on their daily locomotor activity levels.
Consistent with previously reported find-
ings (Chen et al., 2005), diet-restricted
Sirt1/ mice failed to show significant
increases in general ambulatory or rearing
activity over a 24 h light/dark cycle,
whereas diet-restricted Sirt1/mice sig-
nificantly increased these indices of activ-
ity compared to levels observed during ad
libitum-fed state (Sirt1/ vs Sirt1/,
total ambulations in DR, p  0.03; rear-
ings in DR, p  0.037) (Fig. 4A; supple-
mental Table S1, available at www.
jneurosci.org as supplemental material)
(Yu et al., 1985; Chen et al., 2005). Fur-
thermore, Sirt1/ mice only showed
marginal increases in FAA compared to
controls in the timed DR paradigm
(ZT0–6, p 0.001) (Fig. 4B).
We also compared levels of hypotha-
lamic neural activation in Sirt1/ and
controlmice under different diet-restricting
conditions. In contrast to BRASTO mice,
Sirt1/mice showed significantly lower
numbers of cFOS-positive cells in both
theDMHandLHcompared to controls in
response to 14 d DR (DMH, p  0.006;
LH, p 0.001) (Fig. 4C, left panel). With
this genetic background, we also detected
a small but significant difference in the
Arc between Sirt1/ and Sirt1/ mice.
After 48 h fasting, the Sirt1/DMH also
showed significantly lower numbers of
cFOS-positive cells compared to the
Sirt1/DMH, although the Sirt1/ LH
did not show a decrease in this genetic
background and condition (DMH, p 
0.011; LH, p  0.611) (Fig. 4C, middle
panel). In the timed DR paradigm, a sig-
nificant decrease in the number of cFOS-
positive cells was again observed in the
Sirt1/ DMH at ZT4 ( p  0.033) (Fig.
4C, right panel). Consistent with lower
levels of neural activation in the Sirt1/
DMH and LH, Sirt1/mice were unable to maintain the range
of rectal body temperature detected in Sirt1/mice in response to
these diet-restricting conditions (Sirt1/ vs Sirt1/, DR, p 
0.049; fasted, p 0.001) (Fig. 4D,E; supplemental Table S1, avail-
able at www.jneurosci.org as supplemental material). Together,
these findings demonstrate that SIRT1 is necessary for the neurobe-
havioral adaptation to acute and chronic diet-restricting paradigms.
SIRT1 upregulates genes that affect neural signaling and
activity in the DMH and LH
To address the molecular mechanism by which SIRT1 promotes
neural activation in the DMH and LH in response to diet-
restricting conditions, we conducted microarray analyses to
compare gene expression profiles between whole hypothalami
from 48 h fasted BRASTO and control mice. Although none of
the gene expression changes reached statistical significance in this
particular experiment (data not shown), we noted that several
genes previously reported to regulate neural signaling and activ-
ity might have important functional connections to the observed
phenotypes in BRASTO mice, including the genes encoding
orexin type 2 receptor (OX2R) (Sakurai et al., 1998), cortico-
tropin releasing hormone receptor 1 (CRHR1) (Mu¨ller and
Wurst, 2004), and Ca2-activated K channel (BK) 2 subunit
(KCNMB2) (Dai et al., 2009).We reexaminedmRNA expression
Figure 4. Sirt1-deficient mice have defects in neurobehavioral adaptation to diet-restricting conditions. A, Numbers of total
ambulations (left) and rearings (right) of Sirt1/ and Sirt1/ mice under AL and 14 d DR conditions are shown as mean
values SEM (*p 0.05 by one-way ANOVAwith Tukey–Kramer post hoc test, n 5mice).B, Wheel-running activity levels of
Sirt1/ and Sirt1/ mice during a timed DR paradigm. Activity counts per hour of control mice (left) and Sirt1/ mice
(right) througha24h light/dark cycle are shown. Shading represents feeding time (ZT6 to10). Counts at each timepoint are shown
as mean values SEM (day 0 vs day 5, *p 0.05, **p 0.01, ***p 0.001 by paired Student’s t or Wilcoxon matched-pairs
signed-ranks tests; Sirt1/ vs Sirt1/, †p 0.001 by aWilcoxonmatched-pairs signed-ranks test, n 9 and 4 for Sirt1/
and Sirt1/mice, respectively).C, Quantification of the number of cFOS-positive cells in hypothalamic nuclei after 14 dDR (left),
48 h fasting (middle), and 5 d of timedDR (right) in Sirt1/mice (*p 0.05, **p 0.01, ***p 0.001, n 3mice for DR and
fasting, 6–9 sections per hypothalamic nucleus; n 2mice for timed DR, 2–7 sections per hypothalamic nucleus). The numbers
of cFOS-positive cells are shown as mean values SEM. D, E, Rectal body temperature of Sirt1/ and Sirt1/mice during
14 d DR (D) and after 48 h fasting (E). Levels of rectal body temperature are shown as mean values SEM (*p 0.05, ***p
0.001 by one-way ANOVA with Tukey–Kramer post hoc test, n 5–10 for 48 h fasting, n 5 for DR).
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levels of those genes in 48 h fasted BRASTO, Sirt1/, and con-
trol mice by qRT-PCR. Interestingly, all three genes showed op-
posite directions of changes betweenBRASTOand Sirt1/mice
(supplemental Fig. S9, available at www.jneurosci.org as supple-
mental material). In particular, Ox2r and Kcnmb2 exhibited in-
creases in BRASTO hypothalami and remarkable decreases in
Sirt1/ hypothalami, compared to respective controls. In con-
trast, theorexin type1receptorgene(Ox1r) (Sakurai et al., 1998)and
the L-type voltage-gated Ca2 channel subtype Cav1.3 gene, whose
product is functionally coupled with BK channels (Berkefeld et al.,
2006), did not show any changes in fasted BRASTO and Sirt1/
hypothalami (supplemental Fig. S9, available at www.jneurosci.org
as supplemental material). Given that
only specific hypothalamic nuclei exhib-
ited significant neural activation in
BRASTO mice (Fig. 3A–C), we suspected
that local changes in gene expression
might be averaged out through the whole
hypothalamus. To analyze such local
changes in the expression ofOx2r andKc-
nmb2, we conducted in situ hybridization
through multiple independent brain sec-
tions from 48 h-fasted BRASTO and
Sirt1/ mice. More Ox2r-positive cells
were clearly detected in theDMHand LH,
but not in other hypothalamic nuclei, of
BRASTOmice compared to those of wild-
type controls (Fig. 5A). When assessing
total signal levels in the VMH, DMH, and
LH, Ox2r signal levels showed an 80%
increase selectively in the BRASTO DMH
and LH relative to wild-type controls
(DMH, p 0.02; LH, p 0.028) (Fig. 5B).
qRT-PCR results with laser-micro-
dissected samples of each hypothalamic
nucleus also confirmed that Ox2r expres-
sion levels increased specifically in the
BRASTO DMH and LH compared to
wild-type controls (DMH, p 0.038; LH,
p 0.049) (Fig. 5C,D), consistentwith the
observed enhancement of neural activa-
tion in the BRASTO DMH and LH under
diet-restricting conditions (Fig. 3A–C). Kc-
nmb2 signal levels increased in 48 h-fasted
BRASTO hypothalami compared to con-
trol hypothalami, but this increase was
not limited to the DMH and LH (supple-
mental Fig. S10, available at www.
jneurosci.org as supplemental material).
Conversely, fasted Sirt1/ mice showed
fewer Ox2r-positive cells and decreases in
total Ox2r signal levels in the DMH, but
not in the LH, compared to fasted
Sirt1/mice (DMH, p 0.038; LH, p
0.769) (Fig. 5E,F), also consistent with
significant decreases in neural activation
in the DMH of fasted Sirt1/mice (Fig.
4C). Given that OX2R and orexin signal-
ing have been reported to play an im-
portant role in the regulation of sleep,
physical activity, and metabolism
(Sakurai et al., 1998; Chemelli et al., 1999;
Funato et al., 2009), these results suggest
that theOx2r genemight be a critical target of SIRT1 in the DMH
and LH in response to diet-restricting conditions.
Diet restriction augmentsOx2r expression in the DMH and
LH through SIRT1
To test whether Ox2r expression is indeed induced by SIRT1 in
response to DR, we examined Ox2r expression profiles in hypo-
thalami of diet-restricted wild-type mice. Similar to the results in
BRASTO hypothalami (Fig. 5A,B), DR increased the number of
Ox2r-positive cells and total Ox2r signal levels significantly and
specifically in theDMHand LH, but not in the VMH (DMH, p
0.002; LH, p  0.028; VMH, p  0.718) (Fig. 6A,B). This DR-
Figure 5. SIRT1 upregulates genes that affect neural signaling and activity in the DMH and LH. A, The in situ hybridization of
Ox2r (green) in the DMH and LH in BRASTO mice fasted for 48 h. Nuclei were counterstained by DAPI (blue). Upper panel, Sense
probe hybridization onwild-type sections;middle and lower panels, antisense probe hybridization onwild-type (WT) and BRASTO
(Tg) sections. B, Quantification of signal levels of Ox2rmRNA in the VMH, DMH and LH. Results are shown as mean values SEM
(*p 0.05, n 3–4 mice for each genotype, 3–8 sections per hypothalamic nucleus). C, D, Laser-microdissection of hypotha-
lamic nuclei (C), and Ox2r expression levels in the Arc, VMH, DMH, and LH by real-time qRT-PCR (D). Results are shown as mean
values SEM (*p 0.05, n 4 mice for each genotype). E, F, The in situ hybridization of Ox2r (green) in the DMH and LH in
Sirt1/ and Sirt1/mice fasted for 48 h (E), and signal levels of Ox2r mRNA in the VMH, DMH, and LH are shown as mean
values SEM (F ) (*p 0.05, n 2–3 mice for each genotype, 3–6 sections per hypothalamic nucleus).
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induced enhancement ofOx2r expression
was totally abrogated in the Sirt1/
DMH and LH (DMH, p 0.013; LH, p
0.015; VMH, p 0.203) (Fig. 6C,D), sug-
gesting that SIRT1 is required for DR-
induced enhancement ofOx2r expression
in the DMH and LH. Furthermore, we
found that SIRT1 was able to enhance the
activity of the Ox2r promoter in a dose-
dependentmanner in cultured cells (1g,
p 0.005; 2 g, p 0.001) (Fig. 6E). To
validate the relevance of this in vitro result,
we also conducted chromatin-immuno-
precipitation (ChIP) assays with isolated
mouse hypothalami to examine whether
SIRT1 resides in the Ox2r promoter re-
gion in vivo. ChIP analyses revealed that
SIRT1 resided specifically in the Ox2r
proximal promoter region spanning from
110 bp to 457 bp (Fig. 6F). Thus,
these findings suggest that increased
SIRT1 activity in BRASTO and diet-
restricted hypothalami enhancesOx2r ex-
pression and promotes neural activation
specifically in the DMH and LH, which
tightly correlates with enhanced physical
activity in response to diet-restricting
conditions.
The gut hormone ghrelin induces
enhanced neural activation in
BRASTO hypothalami
Because DR apparently imposes a signal
that stimulates DMH and LH neurons in
both wild-type and BRASTO mice, we
suspected that some hormones produced
in peripheral tissues in response to DR
might generate such a stimulatory signal
in the hypothalamus. We were particu-
larly interested in ghrelin, an orexigenic
hormone secreted from stomach, because
ghrelin has been reported to stimulate
orexin neurons in LH (Horvath et al.,
2001) and in culture (Yamanaka et al.,
2003). It has also been shown that periph-
eral injection of ghrelin increases the num-
ber of cFOS-positive cells in the DMH in
rats (Kobelt et al., 2008). Therefore, we hy-
pothesized that ghrelin contributes to the
peripheral signal responsible for stimulating
DMHandLHneurons in response toDR inwild-type andBRASTO
mice. We first examined serum ghrelin levels in AL and diet-
restricted mice. Ghrelin levels significantly increased in mice under
DR, compared to those in AL mice ( p 0.006) (Fig. 7A, left). Gh-
relin levels also increased similarly in both 48 h fasted control and
BRASTOmice (WT, p 0.001; Tg, p 0.001) (Fig. 7A, right; sup-
plementalTable S1, available atwww.jneurosci.org as supplemental
material). We next compared neural activation in control and
BRASTO hypothalami to peripheral ghrelin injection. After 4 d of
habituation to handling andmock injection to avoid stress-induced
neural activation, we injected PBS or ghrelin intraperitoneally into
both control and BRASTO mice. Whereas control PBS injection
showed minimal cFOS induction with no baseline differences be-
tweenwild-type andBRASTOmice, ghrelin induced cFOS-positive
cells in the Arc, DMH, and LH over 2 h after injection, and the
BRASTO DMH and LH showed significantly higher numbers of
cFOS-positive cells than control DMH and LH after ghrelin in-
jection (WT vs Tg, DMH, p  0.017; LH, p  0.019) (Fig. 7B).
Consistent with this DMH- and LH-specific enhancement of
neural activation in BRASTO mice, they were also able to main-
tain higher levels of rectal body temperature compared to con-
trols after ghrelin injection (WT vs Tg, p  0.048) (Fig. 7C;
supplemental Table S1, available at www.jneurosci.org as supple-
mental material), which mimics the changes in rectal body tem-
perature observed in diet-restricted wild-type and BRASTOmice
(Fig. 3E). Interestingly, the majority of cFOS-positive cells were
Figure 6. Diet restriction augmentsOx2r expression in the DMH and LH via SIRT1.A–D, In situ hybridization ofOx2r in the DMH
andLH inwild-type C57BL/6malemice (A,B) and Sirt1/ FVBmalemice (C,D) under 14dDR.Ox2r signal levelswere quantified
in each hypothalamic nucleus under AL and 14 d DR (B) and between diet-restricted Sirt1/ and Sirt1/mice (D). The signal
intensity per area was digitally quantified after subtracting surrounding background. Results are shown as mean values SEM
(*p 0.05, **p 0.01, n 3–4 each for AL and DRmice (4–10 sections and per hypothalamic nucleus) and for Sirt1/ and
Sirt1/mice (2–8sectionsperhypothalamicnucleus)).E, Luciferaseactivitiesweremeasuredby transfectingHEK293 cellswith
a luciferase reporter driven by a1 kb Ox2r promoter and a Sirt1minigene or a control vector carrying only the Sirt1 promoter.
Luciferaseactivitieswere comparedwith increasingamountsof theSirt1minigene. The luciferaseactivities in cells transfectedwith
the promoter-only control vector are normalized to 100%. Results are shown asmean values SEM (**p 0.01, ***p 0.001
by one-way ANOVAwith Tukey–Kramer post hoc test, n 4). F, Chromatin immunoprecipitation for SIRT1 in the hypothalamus.
Fixed chromatinwas sonicated and subjected to immunoprecipitationwith an anti-SIRT1 polyclonal antibody. Extracted DNAwas
amplifiedwitheachprimer set. Primer set 1wasdesigned for anunrelatedgenomic region. Locationsof primer sets 2–4are shown
in the upper panel. Rabbit IgG (rIgG) was used as a negative control.
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also OX2R-positive (82 and 72% in the Arc, 77 and 79% in the
DMH, and 57 and 72% in the LH in control and BRASTO mice,
respectively, at 120min after ghrelin injection) (Fig. 7D), and the
numbers of cFOS/OX2R-double-positive cells were significantly
higher in the BRASTODMHandLHcompared to controls at 120
min after ghrelin injection (DMH, p  0.015; LH, p  0.012)
(Fig. 7E). We also examined the response of Sirt1/ and
Sirt1/ mice to peripheral ghrelin injection. Among all acti-
vated neurons, the percentages of cFOS/OX2R-double-positive
cells were significantly lower in the Sirt1/ DMH and LH
(DMH, p 0.001; LH, p 0.042) (Fig. 7F), suggesting that the
response to ghrelin through OX2R is sig-
nificantly reduced in the Sirt1/ LH and
DMH. Together, our findings indicate that
peripheral ghrelin, whose levels are signifi-
cantly increased by diet-restricting condi-
tions, triggers the stimulatory signal in the
DMH and LH where SIRT1 enhances the
responsiveness of neurons through the aug-
mentation ofOx2r expression.
Discussion
SIRT1 functions as a key mediator for
the central adaptation to
diet restriction
In this study, we provide several lines of
evidence demonstrating the physiological
significance of SIRT1 in the regulation of
neurobehavioral adaptation to DR: (1)
SIRT1 protein levels and neural activation
are induced specifically in the DMH and
LH by DR, (2) increased SIRT1 dosage in
the brain significantly enhances neural ac-
tivation in the DMH and LH, maintains a
higher range of body temperature, and
promotes physical activity in BRASTO
mice in response tomultiple diet-restricting
paradigms, (3) these responses induced by
diet-restricting conditions are abrogated
by SIRT1 deficiency, (4) SIRT1 is required
for the DR-induced enhancement ofOx2r
expression in theDMHand LH and is also
able to enhance the promoter activity of
the Ox2r gene, and (5) ghrelin, a gut hor-
mone whose plasma levels are signifi-
cantly increased by both 48 h fasting and
DR, stimulates OX2R-positive neurons in
the DMH and LH and maintains higher
body temperature in BRASTOmice, while
Sirt1/mice show significantly reduced
neural activation through OX2R in the
DMHand LH. These findings suggest that
SIRT1 controls a central adaptive mecha-
nism by which animals maintain their
physical activity and body temperature in
response to relatively chronic energy lim-
itation. Given that BRASTOmice show an
enhancement of these neurobehavioral
responses to DR, whereas Sirt1/ mice
exhibit defects in these responses, persis-
tent low energy intake such as DR likely
triggers this adaptive mechanism by aug-
menting SIRT1 activity and thereby Ox2r
expression, at least in part, in the DMH
and LH and enhancing the sensitivity of OX2R-positive neurons
to signals imposed possibly by peripheral ghrelin.
A novel central connection between SIRT1 and OX2R-
mediated orexin signaling
Our finding that SIRT1 enhances Ox2r expression specifically in
the DMH and LH in response to DR illustrates a novel central
connection between two key players in the regulation of metab-
olism and behavior. Orexin-OX1/2R signaling has been demon-
strated to play a critical role in the central regulation of arousal,
Figure 7. Ghrelin stimulates OX2R-positive neurons in the BRASTODMHand LH, but not in Sirt1-deficientmice.A, Serum levels
of ghrelin in AL and DR wild-type mice (left) and in fed and fasted BRASTO (Tg) and control (WT) mice (right). Ghrelin levels are
shown as mean values SEM (**p 0.01, ***p 0.001 by one-way ANOVAwith Tukey–Kramer post hoc test, n 5 for each
condition). B, The number of cFOS-positive cells in the Arc, DMH, and LH of wild-type (WT) and BRASTO (Tg) mice at 90 min (left)
and 120 min (right) after ghrelin injection (30 nmol/kg of body weight) and after PBS injection (right). cFOS-positive cells are
shownasmeanvaluesSEM(*p0.05, **p0.01byone-wayANOVAwithTukey–Kramerpost hoc test for eachhypothalamic
nucleus, ghrelin injection, 90min, n 2–3mice for each genotype, 7–12 sections per hypothalamic nucleus; 120min, n 3 for
each genotype, 3–7 sections per hypothalamic nucleus, PBS injection, n 2 for each genotype, 6–7 sections per hypothalamic
nucleus). C, Rectal body temperature of BRASTOmice 120min after ghrelin injection. Levels of rectal body temperature are shown
as mean values SEM (*p 0.05, **p 0.01 by one-way ANOVA with Tukey–Kramer post hoc test, n 6–7). D, Double
immunofluorescent staining of cFOS andOX2R in theDMHand LHofwild-type (WT) andBRASTO (Tg)mice at 120min after ghrelin
injection. Arrows indicate cFOS/OX2R-double-positive cells. E, Quantification of the number of cFOS/OX2R-double-positive cells in
the Arc, DMH and LH of wild-type (WT) and BRASTO (Tg) mice at 120min after ghrelin injection. cFOS/OX2R-double-positive cells
are shown as mean values SEM (*p 0.05, n 3 mice for each genotype, 3–7 sections per hypothalamic nucleus). F,
Percentage of cFOS/OX2R-double-positive cells compared to a total number of cFOS-positive cells in the Arc, DMH, and LH of
Sirt1/ and Sirt1/ mice at 120 min after ghrelin injection. Percentages of cFOS/OX2R-double-positive cells are shown as
mean values SEM (*p 0.05, ***p 0.001, n 3 mice for each genotype, 6–12 sections per hypothalamic nucleus). G, A
model for the SIRT1-mediated neurobehavioral adaptation in the hypothalamus in response to DR. See Discussion for details.
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motivational components of physical activity, and metabolism
(Sakurai et al., 1998; Chemelli et al., 1999; Funato et al., 2009). In
particular, hypothalamic orexin signaling plays an essential role
in the fasting-induced enhancement of wakefulness and locomo-
tor activity (Yamanaka et al., 2003). It has also been shown that
orexin neuron-ablated mice have a severe defect in the food-
anticipatory enhancement of wakefulness and locomotor activity
under timed DR (Mieda et al., 2004). It has recently been dem-
onstrated that orexin-OX2R signaling regulates metabolic rate,
food intake, and leptin and insulin sensitivity and thereby con-
veys resistance to high-fat diet-induced metabolic complications
(Funato et al., 2009). Thus, hypothalamic orexin signaling func-
tions as a critical mediator of central adaptive responses to alter-
ations in energy intake.
Similarly, it has been well established that SIRT1 mediates a
variety of criticalmetabolic effects in response to nutritional cues,
particularly to low nutritional input, in major metabolic tissues,
such as liver, adipose tissue, and skeletal muscle (Sinclair, 2005;
Imai and Guarente, 2007; Schwer and Verdin, 2008; Imai and
Guarente, 2010). Most recently, it has been reported that phar-
macological inhibition or Arc-specific knockdown of hypotha-
lamic SIRT1 suppresses food intake and body weight gain, likely
through the central melanocortin signaling, in rats (Cakir et al.,
2009). SIRT1 is expressed in pro-opiomelanocortin (POMC)
neurons (Ramadori et al., 2008) and appears to regulate Pomc
expression through deacetylation of FOXO1 (Cakir et al., 2009).
These studies reveal hypothalamic SIRT1 function in response to
acute nutritional deprivation. Our present study further extends
this interesting aspect of SIRT1 function in the hypothalamus
and reveals a new metabolic role of SIRT1 in different hypotha-
lamic nuclei, namely the DMH and LH, in response to more
chronic nutritional alterations. SIRT1 appears to control the sen-
sitivity of a particular subset of neurons in the DMH and LH
through the regulation ofOx2r expression andmakes themmore
responsive to increased ghrelin signal under DR (Fig. 7G). Be-
cause ghrelin directly stimulates orexin neurons (Horvath et al.,
2001; Yamanaka et al., 2003), it is highly likely that those OX2R-
positive DMH and LH neurons are stimulated by the orexin neu-
rons that are activated by ghrelin (Fig. 7G). Although further
investigation will be necessary to clarify the entire signaling cas-
cade, the augmentation of OX2R-mediated neural activation in
response to DR appears to be accomplished by the localized in-
crease in SIRT1 protein levels in the DMH and LH. Nonetheless,
because BRASTOmice do not show significant phenotypes in AL
conditions, hypothalamic SIRT1 activity might also be aug-
mented by increased systemic NAD biosynthesis or other mech-
anisms activated by low nutritional input, as reported in other
cases (Cakir et al., 2009; Imai, 2009b). Detailed analyses are cur-
rently underway to elucidate the molecular mechanism by which
SIRT1 augments Ox2r expression specifically in the DMH and
LH in response to low nutritional input.
The SIRT1-mediated systemic regulatory network for
adaptive responses to diet restriction
It should be noted that persistent neural activation is observed in
the DMH and LH under DR, although other hypothalamic nu-
clei, such as the Arc and VMH, might be involved in regulatory
processes that trigger metabolic changes at an early stage during
DR. Our findings suggest that SIRT1 in the OX2R-positive DMH
and LH neurons might play a critical role in coordinating meta-
bolic responses to chronic diet-restricting conditions at a sys-
temic level. Although their precise nature is currently unclear, the
activation of theseOX2R-positiveDMHand LHneurons leads to
the stimulation of thermogenesis and the elevation of physical
activity in response to relatively chronic diet-restricting condi-
tions. Increasing SIRT1 dosage further promotes these responses,
whereas SIRT1 deficiency abrogates them. Given that it has been
shown that DMH and LH neurons regulate thermogenesis in
brown adipose tissue through the control of sympathetic nerve
activity (Cerri andMorrison, 2005; DiMicco and Zaretsky, 2007;
Morrison et al., 2008), it is tempting to speculate that SIRT1
activity in these neurons might affect such systemic responses
through the regulation of sympathetic nerve activity.However, in
light of the complexity of hypothalamic circuits, the fact that
some hypothalamic nuclei appear to bemore homogeneous than
others in their responses does not necessarily allowus to conclude
that those particular nuclei are central in such systemic responses.
Definitive tests await the generation of necessary genetic tools,
such as DMH- or LH-specific Cre-driver mice. Nonetheless, it
will also be of great importance to examine where these OX2R-
positive DMH and LH neurons send their projections and which
neurons control activities of those DMH and LH neurons.
It is conceivable that those specific hypothalamic neurons, as
well as other hypothalamic neurons such as AgRP and POMC
neurons, might also be important for age-associated alterations
in neurobehavioral adaptive responses to nutritional inputs and
possibly for longevity as well in mammals, given that it has been
demonstrated that a very specific subset of sensory neurons,
namely SKN-1-positive neurons, mediates DR-induced longev-
ity through an endocrine mechanism in C. elegans (Bishop and
Guarente, 2007b). Such a hierarchical regulatory network might
play a universal role in the regulation of aging and longevity in
animals, and SIRT1might be an integral component in the DMH
and LH to modulate systemic signals in response to changes in
energy intake in mammals. Indeed, peripheral administration of
ghrelin, an orexigenic hormone produced in the stomach, trig-
gers the activation of the DMH and LH neurons and induces
changes in body temperature, mimicking the effect of DR. In-
creased SIRT1 dosage enhances this neural response to ghrelin
and allows animals to maintain a higher range of body tempera-
ture. Therefore, SIRT1 might function as a critical modulator in
this hierarchical regulatory network for the regulation of central
adaptive responses. Alteration in SIRT1 activity in these neurons
might cause significant changes in the system dynamics of this
adaptive mechanism. In this regard, it is intriguing that systemic
NADbiosynthesis appears to decline over age, resulting in reduc-
tions in SIRT1 activity and glucose-stimulated insulin secretion
in pancreatic  cells in aged mice (Ramsey et al., 2008; Imai,
2009b). Such an age-associated decrease in systemic NAD bio-
synthesis might contribute to the alteration of certain neurobe-
havioral adaptations, such as reducedmotivation for activity and
sleep disorders, both of which are common in the elderly (Kmiec,
2006).
In conclusion, our present study demonstrates the physio-
logical significance of SIRT1 as a key central mediator for the
neurobehavioral adaptation to DR. These findings provide
critical insights into the molecular mechanism by whichmam-
mals control their neurobehavioral adaptive responses to
search for food and to survive through diet-restricted, life-
threatening environments.
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